Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial
National Institute of Allergy and Infectious Diseases (NIAID)
Daniel J Jackson; Leonard B Bacharier; Peter J Gergen; Lisa Gagalis; Agustin Calatroni; Stephanie Wellford; Michelle A Gill; Jeffrey Stokes; Andrew H Liu; Rebecca S Gruchalla; Robyn T Cohen; Melanie Makhija; Gurjit K Khurana Hershey; George T O'Connor; Jacqueline A Pongracic; Michael G Sherenian; Katherine Rivera-Spoljaric; Edward M Zoratti; Stephen J Teach; Meyer Kattan; Cullen M Dutmer; Haejin Kim; Carin Lamm; William J Sheehan; R Max Segnitz; Kimberly A Dill-McFarland; Cynthia M Visness; Patrice M Becker; James E Gern; Christine A Sorkness; William W Busse; Matthew C Altman; US National Institute of Allergy and Infectious Disease's Inner City Asthma Consortium